Email this article 
Treatment results of Hodgkin’s lymphoma in children and adolescents: data of a monocenter study
- Authors: Feoktistov R.I.1,2, Rumyantseva J.V.2, Abugova Y.G.1,2, Dyakonova Y.Y.1,2, Makarova O.V.1,2, Myakova N.V.1,2, Samochatova E.V.1,2
-
Affiliations:
- Russian Children Clinical Hospital
- Federal Research Center of Pediatric Hematology, Oncology and Immunology
- Issue: No 2 (2010)
- Pages: 6-12
- Section: HEMATOLOGIC MALIGNANCIES: DIAGNOSIS, TREATMENT, SUPPORTIVE CARE
- Published: 24.05.2010
- URL: https://oncohematology.abvpress.ru/ongm/article/view/695
- ID: 695
Cite item
Full Text
Abstract
Treatment results of children and adolescents with Hodgkin’s lymphoma (HL) treated at the Russian Children Clinical Hospital (Moscow) was described. 47 children and adolescents with HL were treated by modified DAL-HD-90 protocol. 45 (95.74 %) patients achieved remission. With a median follow-up time of 57.6 month 6-years overall, event-free and relapse-free survival were 95 ± 3, 91 ± 4 and 95 ± 3 %, respectively. The age 14 years and older and the 2 type nodular sclerosis of Hodgkin’s lymphoma were the poor prognostic factors.
About the authors
R. I. Feoktistov
Russian Children Clinical Hospital; Federal Research Center of Pediatric Hematology, Oncology and Immunology
Author for correspondence.
Email: feoktistov-r@yandex.ru
Moscow
Russian FederationJ. V. Rumyantseva
Federal Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationYu. G. Abugova
Russian Children Clinical Hospital; Federal Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationYu. Yu. Dyakonova
Russian Children Clinical Hospital; Federal Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationO. V. Makarova
Russian Children Clinical Hospital; Federal Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationN. V. Myakova
Russian Children Clinical Hospital; Federal Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationE. V. Samochatova
Russian Children Clinical Hospital; Federal Research Center of Pediatric Hematology, Oncology and Immunology
Moscow
Russian FederationReferences
Supplementary files
